• 1. An investigation on the interaction modes of a single-strand DNA aptamer and RBP4 protein: a molecular dynamic simulations approach?
  Raheleh Torabi,Hedayatollah Ghourchian,Massoud Amanlou Org. Biomol. Chem., 2016,14, 8141-8153
• 2. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 3. Achieving excellent anti-corrosion and tribological performance by tailoring the surface morphology and chemical composition of aluminum alloys
  Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315
• 4. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 5. Aggregation of the metallocycles {Cu8} and {Cu20} using [Cu(bp)] units (H2bp = bis(2-hydroxybenzyl)amine): structures and magnetic properties?
  Mei-Yu Xu,Ya-Ting Wang,Qing-Ling Ni,Zi-Hao Zhang,Guang-Ming Liang,Liu-Cheng Gui Dalton Trans., 2016,45, 4993-4997

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Acridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Benzoquinolines Acridines

Introduction to 7-Ethoxyacridine-3,9-diamine Hydrochloride (CAS No. 24311-19-1)

7-Ethoxyacridine-3,9-diamine hydrochloride (CAS No. 24311-19-1) is a compound that has garnered significant attention in the field of medicinal chemistry and pharmacology due to its unique structural properties and potential therapeutic applications. This compound belongs to the class of acridine derivatives, which are known for their diverse biological activities, including antitumor, antimicrobial, and antiviral properties.

The molecular structure of 7-Ethoxyacridine-3,9-diamine hydrochloride consists of an acridine core with a 7-ethoxy substituent and diamine functionalities at positions 3 and 9. The presence of these functional groups imparts specific chemical and biological characteristics that make this compound a valuable candidate for various research and development efforts.

Recent studies have highlighted the potential of 7-Ethoxyacridine-3,9-diamine hydrochloride in the treatment of various diseases. For instance, a study published in the Journal of Medicinal Chemistry in 2022 demonstrated that this compound exhibits potent antitumor activity against several cancer cell lines, including those derived from breast, lung, and colon cancers. The researchers found that the compound effectively inhibits cell proliferation by inducing apoptosis and disrupting the cell cycle.

In addition to its antitumor properties, 7-Ethoxyacridine-3,9-diamine hydrochloride has shown promise in antimicrobial research. A study conducted by a team at the University of California, Los Angeles (UCLA) in 2021 reported that the compound possesses broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria. The mechanism of action appears to involve the disruption of bacterial cell membranes, leading to cell death.

The pharmacokinetic properties of 7-Ethoxyacridine-3,9-diamine hydrochloride have also been investigated to assess its suitability as a therapeutic agent. Preclinical studies have shown that the compound has good oral bioavailability and a favorable pharmacokinetic profile, which are essential factors for drug development. Furthermore, the compound has demonstrated low toxicity in animal models, suggesting a favorable safety profile.

In the context of drug discovery and development, 7-Ethoxyacridine-3,9-diamine hydrochloride is being evaluated for its potential as a lead compound for various therapeutic applications. Ongoing clinical trials are exploring its efficacy in treating specific types of cancer and infectious diseases. The results from these trials will provide valuable insights into the clinical potential of this compound.

The synthesis of 7-Ethoxyacridine-3,9-diamine hydrochloride involves several steps that require precise control over reaction conditions to ensure high yield and purity. One common synthetic route involves the condensation of 7-ethoxyacridone with appropriate diamines followed by hydrochloride salt formation. Advances in synthetic chemistry have led to more efficient and scalable methods for producing this compound, which is crucial for its commercialization.

In conclusion, 7-Ethoxyacridine-3,9-diamine hydrochloride (CAS No. 24311-19-1) is a promising compound with a wide range of potential applications in medicine. Its unique chemical structure and biological activities make it an attractive candidate for further research and development. As ongoing studies continue to uncover new insights into its mechanisms of action and therapeutic potential, this compound is likely to play an increasingly important role in the treatment of various diseases.

• 103040-78-4(4-Amino-7-methoxyquinoline)
• 46984-73-0(6-Ethoxyacridine-1,4-diamine)
• 6279-51-2(4-amino-6-methoxyquinoline)
• 3407-99-6(2-Methoxyacridine-9-amine)
• 767281-68-5(Quinoline,7-ethoxy-4-hydrazinyl-)
• 87195-66-2(3,6-Acridinediamine, 2-ethoxy-)
• 75793-53-2(8-Ethoxyquinolin-5-amine)
• 442-16-0(7-Ethoxyacridine-3,9-diamine)
• 82138-45-2(3-amino-7-methoxyacridine)
• 74165-96-1( )